Employees: 12 (2023.0)Legal category: 5485Size: PMECreation date: 2003-07-25 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VIRE-NORMANDIE (14500), Calvados
SELARL PHARMACIE LAIR - PORTE HORLOGE : revenue, balance sheet and financial ratios
SELARL PHARMACIE LAIR - PORTE HORLOGE is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VIRE-NORMANDIE (14500),
this company of category PME
shows in 2023 a revenue of 5.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE LAIR - PORTE HORLOGE (SIREN 449526342)
Indicator
2024
2023
2022
2021
2019
2018
2017
Revenue
N/C
5 242 175 €
N/C
3 322 727 €
4 797 146 €
4 956 109 €
5 078 838 €
Net income
414 595 €
230 193 €
330 922 €
153 865 €
192 783 €
295 782 €
1 897 366 €
EBITDA
N/C
273 598 €
N/C
129 914 €
171 295 €
427 288 €
425 722 €
Net margin
N/C
4.4%
N/C
4.6%
4.0%
6.0%
37.4%
Revenue and income statement
In 2024, SELARL PHARMACIE LAIR - PORTE HORLOGE generates positive net income of 415 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 1.9 M€ -> 415 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
414 595 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 2%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 90%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
2.366%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
89.843%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE LAIR - PORTE HORLOGE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2023
2024
Debt ratio
12.118
7.03
2.451
1.846
2.116
1.972
2.366
Financial autonomy
79.52
84.017
87.778
87.678
87.493
89.65
89.843
Repayment capacity
2.798
1.363
0.753
0.714
None
0.507
None
Cash flow / Revenue
4.827%
6.198%
4.141%
5.009%
None%
5.194%
None%
Sector positioning
Debt ratio
2.372024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Excellent
In 2024, the debt ratio of SELARL PHARMACIE LAIR - P... (2.37) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
89.84%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Excellent+13 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE LAIR - P... (89.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.51 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of SELARL PHARMACIE LAIR - P... (0.51) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 555.40. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
555.405
Liquidity indicators evolution SELARL PHARMACIE LAIR - PORTE HORLOGE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2021
2022
2023
2024
Liquidity ratio
414.773
313.054
244.642
286.014
338.664
434.165
555.405
Interest coverage
1.38
0.891
1.013
0.0
None
0.0
None
Sector positioning
Liquidity ratio
555.42024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of SELARL PHARMACIE LAIR - P... (555.40) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.0x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of SELARL PHARMACIE LAIR - P... (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE LAIR - PORTE HORLOGE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2023
2024
Operating WCR
756 391 €
780 191 €
768 407 €
676 906 €
0 €
890 016 €
0 €
Inventory turnover (days)
52
48
47
69
0
51
0
Customer payment term (days)
8
9
8
14
0
12
0
Supplier payment term (days)
49
50
52
84
0
41
0
Positioning of SELARL PHARMACIE LAIR - PORTE HORLOGE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE LAIR - PORTE HORLOGE is estimated at
5 788 052 €
(range 4 030 708€ - 8 659 258€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
4030k€5788k€8659k€
5 788 052 €Range: 4 030 708€ - 8 659 258€
NAF 5 année 2024
Valuation method used
Net Income Multiple
414 595 €
×
14.0x
=5 788 053 €
Range: 4 030 708€ - 8 659 258€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE LAIR - PORTE HORLOGE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE LAIR - PORTE HORLOGE
What is the revenue of SELARL PHARMACIE LAIR - PORTE HORLOGE ?
The revenue of SELARL PHARMACIE LAIR - PORTE HORLOGE in 2023 is 5.2 M€.
Is SELARL PHARMACIE LAIR - PORTE HORLOGE profitable?
Yes, SELARL PHARMACIE LAIR - PORTE HORLOGE generated a net profit of 415 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE LAIR - PORTE HORLOGE ?
The headquarters of SELARL PHARMACIE LAIR - PORTE HORLOGE is located in VIRE-NORMANDIE (14500), in the department Calvados.
Where to find the tax return of SELARL PHARMACIE LAIR - PORTE HORLOGE ?
The tax return of SELARL PHARMACIE LAIR - PORTE HORLOGE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE LAIR - PORTE HORLOGE operate?
SELARL PHARMACIE LAIR - PORTE HORLOGE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart